Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

CompletedOBSERVATIONAL
Enrollment

76,220

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

September 28, 2019

Study Completion Date

January 10, 2020

Conditions
Hepatitis B
Trial Locations (11)

100120

Xicheng District Center for Disease Prevention and Control, Beijing

101400

Huairou District Center for Disease Prevention and Control, Beijing

102600

Daxing District Center for Disease Prevention and Control, Beijing

Unknown

Chaoyang District Center for Disease Control and Prevention, Beijing

Dongcheng District Center for Disease Control and Prevention, Beijing

Fengtai District Center for Disease Control and Prevention, Beijing

Changping District Center for Disease Prevention and Control, Beijing

FangShan District Center for Disease Prevention and Control, Beijing

Haidian District Center for Disease Prevention and Control, Beijing

Miyun District Center for Disease Prevention and Control, Beijing

Tongzhou District Center for Disease Prevention and Control, Beijing

All Listed Sponsors
lead

Wu Jiang

OTHER_GOV

NCT04264312 - Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria | Biotech Hunter | Biotech Hunter